Home / Blog / Noisy Trumpet / Public Relations / Be Heard: JDRF January PR Coverage

Be Heard: JDRF January PR Coverage

Jan 31, 2022

In honor of the 100th year anniversary of the first successful insulin injection, our PR team conducted strategic outreach efforts in the month of January to bring further awareness to our client JDRF, a nonprofit organization that funds Type 1 diabetes (T1D) research.

We began the month by highlighting a recent CDC study reporting that children who have recovered from COVID-19 are at higher risk of being diagnosed with Type 1 diabetes. With Texas witnessing a record number of cases for children hospitalized with COVID-19, we positioned JDRF as a leading expert who can speak to specific Type 1 diabetes symptoms parents should be aware of. As a result, our team secured a featured segment on KSAT -12 (ABC) San Antonio which was cross-promoted on both broadcast and online platforms.

To build further momentum on JDRF’s expertise, we also brought awareness to the success of their new beta cell clinical trial which utilized stem cell therapy to restore the body’s natural ability to regulate insulin in one patient. This was the first major development in diabetes research since the very first insulin injection treatment 100 years ago – January 23, 1922. These two additional story angles secured notable coverage in top broadcast outlets including KSAT (ABC), WOAI (NBC), and KABB (FOX) – San Antonio.

Within a four-day timespan, in the month of January alone, Noisy Trumpet was able to secure 22 media hits resulting in over 5.5M impressions!

We launched the new year on a very high note for JDRF and are excited to continue our work bringing more exposure to their organization and life changing efforts to find a cure for Type 1 diabetes.